Drugs / Caroxime sodium sulfonate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06255366 | Mar → Dec 2024 | osteoarthritis, spine, spondylolisthesis | Chengdu University of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Caroxime sodium sulfonate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06255366 ↗ |
| Known as | Weiluojing | “trade name: Weiluojing, 100ml, containing caroxime sodium sulfonate 80mg” NCT06255366 ↗ |
| Route | Intravenous | “intravenous infusion of caroxime sodium sulfonate and sodium chloride injection” NCT06255366 ↗ |